The FDA modernisation act 2.0 was passed in late 2022 enabling drug registration without animal studies and bringing microphysiological systems (MPS) to the regulatory table.
To learn more about the act and the future regulatory role of MPS, read our editorial published in Drug Discovery Today: https://www.sciencedirect.com/science/article/pii/S1359644623000120
